Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model

References

• Bello S, Mincholé E, Fandos S, et al. Inflammatory response in mixed viral-bacterial community-acquired pneumonia. BMC Pulm Med. 2014 ;14:123. DOI:10.1186/1471-2466-14-123. pmid:25073709.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Campling J, Dicker A, Woodhead M, Madhava H A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults , et al. BMC pulmonary medicine. 2016;16(1):1–1.
   Google Scholar
• Suvorov A, Ustinovitch I, Meringova L, et al. Construction of recombinant polypeptides based on beta antigen C (Bac) protein & their usage for protection against group B streptococcal infection. Indian J Med Res. 2004;119 Suppl(Suppl 119):228–232.
   PubMedGoogle Scholar
• Rudenko LG. Live attenuated cold-adapted influenza vaccine in Russia: advantages, further research and development. In Katz JM, . editor. Options for the control of influenza VI. London, Atlanta: International Medical Press; 2008. pp. 122–124.
   Google Scholar
• Belshe RB, Ambrose CS, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age. Vaccine. 2008 ;26:D10–6. DOI:10.1016/j.vaccine.2008.06.083.
   PubMed Web of Science ®Google Scholar
• Pebody R, McMenamin J, Nohynek H. Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere. Arch Dis Child. 2018;103(1):101–105.
   PubMed Web of Science ®Google Scholar
• Suvorov A, Dukhovlinov I, Leontieva G, et al. Chimeric protein PSPF, a potential vaccine for prevention Streptococcus. Vaccines Vaccination. 2015;6(6):304.
   Google Scholar
• Akira S, Takeda K, Kaisho T. Toll-Like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675–680. PMID: 11477402.
   PubMed Web of Science ®Google Scholar
• Laiño J, Villena J, Suvorov A, et al. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection. PLoS One. 2018;13(11):e0206661. DOI:10.1371/journal.pone.0206661
   PubMed Web of Science ®Google Scholar
• Gupalova T, Leontieva G, Kramskaya T, et al. Development of experimental pneumococcal vaccine for mucosal immunization. PLoS One. 2019;14(6):e0218679.
   PubMed Web of Science ®Google Scholar
• Kramskaya T, Leontieva G, Desheva Y, et al. Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice. PLoS One. 2019 ;14(9):e0222148.
   PubMed Web of Science ®Google Scholar
• Desheva Y, Leontieva G, Kramskaya T, et al. Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections. PLoS One. 2019 ;14(6):e0218544.
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2019–20 influenza season. MMWR Recommendations Rep. 2019;68(3):1.
   PubMed Web of Science ®Google Scholar
• Landgraf G, Desheva YA, Rudenko LG. Evaluation of influenza a and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines. Virus Res. 2021 : 198396. DOI:10.1016/j.virusres.2021.198396
   PubMed Web of Science ®Google Scholar
• Lu X, Edwards LE, Desheva JA, et al. Cross-Protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza a (H5N1) viruses. Vaccine. 2006 ;24(44–46):6588–6593.
   PubMed Web of Science ®Google Scholar
• Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938 ;27(3):493–497.
   Google Scholar
• Tsuchiya S, Yamabe M, Yamaguchi Y, et al. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 1980;26:171–176.
   PubMed Web of Science ®Google Scholar
• Baz M, M’-Hamdi Z, Carbonneau J, et al. Synergistic PA and HA mutations confer mouse adaptation of a contemporary A/H3N2 influenza virus. Sci Rep. 2019;9(1):1–14.
   PubMedGoogle Scholar
• Cui B, Liu X, Fang Y, et al. Flagellin as a vaccine adjuvant. Expert Rev Vaccines. 2018 ;17(4):335–349.
   PubMed Web of Science ®Google Scholar
• Tessmer A, Welte T, Schmidt-Ott R, et al. Influenza vaccination is associated with reduced severity of community-acquired pneumonia. Eur Respir J. 2011 ;38(1):147–153.
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Luke C, Coelingh K. Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. Influenza Other Respir Viruses. 2008 Nov;2(6):193–202.
   PubMed Web of Science ®Google Scholar
• Peno C, Armitage EP, Clerc M, et al. The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24–59 months in the Gambia: a phase 4, open label, randomised, controlled trial. Lancet Microbe. 2021 ;2:e656–e665. DOI:10.1016/S2666-5247(21)00179-8.
   PubMedGoogle Scholar
• Van Maele L, Fougeron D, Janot L, et al. Airway structural cells regulate TLR5-mediated mucosal adjuvant activity. Mucosal Immunol. 2014;7(3):489–500. DOI:10.1038/mi.2013.66. PMID: 24064672.
   PubMed Web of Science ®Google Scholar
• Zarski LM, Vaala WE, Barnett DC, et al. A live-attenuated equine influenza vaccine stimulates innate immunity in equine respiratory epithelial cell cultures that could provide protection from equine herpesvirus 1. Front Vet Sci. 2021 ;8:674850. DOI:10.3389/fvets.
   PubMed Web of Science ®Google Scholar
• Forero A, Fenstermacher K, Wohlgemuth N, et al. Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells. Vaccine. 2017;35:6112–6121.
   PubMed Web of Science ®Google Scholar
• Fischer IW, Chason KD, Brighton M, et al. Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures. Vaccine. 2014;32:1761–1767.
   PubMed Web of Science ®Google Scholar
• Rathnasinghe R, Salvatore M, Zheng H, et al. Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine. bioRxiv. 2021;11(1):1–2, Jan 1.
   Google Scholar
• Mogensen T, Paludan S. Molecular pathways in virus-induced cytokine production. microbiology and molecular biology reviews. 2001;65(1):131–150. DOI:10.1128/MMBR.65.1.131-150.2001.
   Google Scholar
• Van Reeth K. Cytokines in the pathogenesis of influenza. In: Veterinary microbiology. Vol. 74(1-2). 2000. pp. 109–116.
   Google Scholar
• Herbein G, O’-Brien W. Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Pro Soc Exp Biol Med. 2000;223:241–257.
   PubMed Web of Science ®Google Scholar
• Stetson D, Medzhitov R. Type I interferons in host defense. Immunity. 2006;25:373–381.
   PubMed Web of Science ®Google Scholar
• Wang S, Le T, Kurihara N, et al. Influenza virus–cytokine‐protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J Infect Dis. 2010;202:991–1001.
   PubMed Web of Science ®Google Scholar
• Hu B, Huang S, Yin L. The cytokine storm and COVID‐19. J Med Virol. 2021 Jan;93(1):250–256.
   PubMed Web of Science ®Google Scholar
• Teijaro JR, Walsh KB, Rice S, et al. Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proc Nat Acad Sci. 2014 ;111(10):3799–3804.
   PubMed Web of Science ®Google Scholar
• Rekstin A, Kiseleva I, Klimov A, et al. Interferon and other proinflammatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses. Vaccine. 2006;24:6581–6584.
   PubMed Web of Science ®Google Scholar
• Obermoser G, Presnell S, Domico K, et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity. 2013 ;38(4):831–844.
   PubMed Web of Science ®Google Scholar
• Desheva YA, Leontieva GF, Kramskaya TA, et al. Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection. Heliyon. 2019 ;5(2):e01154.
   PubMed Web of Science ®Google Scholar
• David SC, Norton T, Tyllis T, et al. Direct interaction of whole-inactivated influenza a and pneumococcal vaccines enhances influenza-specific immunity. Nat Microbiol. 2019 Aug;4(8):1316–1327.
   PubMed Web of Science ®Google Scholar
• Bucasas KL, Franco LM, Shaw CA, et al. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J Infect Dis. 2011 ;203(7):921–929.
   PubMed Web of Science ®Google Scholar